What is Leerink Partnrs’ Forecast for Immunic Q2 Earnings?
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Equities research analysts at Leerink Partnrs lifted their Q2 2025 earnings estimates for Immunic in a research note issued on Tuesday, June 3rd. Leerink Partnrs analyst F. Khurshid now forecasts that the company will earn ($0.12) per share for the quarter, up from their previous forecast of ($0.15). […]
